Operations: The company generates SEK 1.05 billion from its healthcare software segment.

Estimated Discount To Fair Value: 49.4%

RaySearch Laboratories, priced at SEK 142, appears undervalued with a fair value estimate of SEK 280.65, reflecting a significant discount of 49.4%. The company's earnings have surged by 356.9% over the past year and are projected to grow by 33.62% annually, outperforming the Swedish market's growth rate of 13.9%. Recent product enhancements and strategic alliances further support operational efficiencies and expansion in treatment capabilities, potentially bolstering future cash flows despite slower revenue growth projections of 10.6% per year compared to the market forecast of 1.7%.

• In light of our recent growth report, it seems possible that RaySearch Laboratories' financial performance will exceed current levels.

• Get an in-depth perspective on RaySearch Laboratories' balance sheet by reading our health report here.

Truecaller

Overview: Truecaller AB (publ) is a company that develops and publishes mobile caller ID applications for individuals and businesses globally, with a market capitalization of approximately SEK 11.94 billion.

Operations: The company generates revenue primarily from its communications software segment, totaling SEK 1.78 billion.

Estimated Discount To Fair Value: 49.7%

Truecaller, trading at SEK 34.52, is significantly undervalued with a fair value estimate of SEK 68.64, marking it as trading below its intrinsic value by over 20%. The company's earnings have expanded by an annual rate of 52.4% over the past five years and are expected to grow at 17.6% annually. Analysts predict a potential price increase of 57.9%. Recent innovations like the AI Call Scanner enhance its competitive edge, potentially driving future revenue and profit growth amidst active share repurchase initiatives.

• Our earnings growth report unveils the potential for significant increases in Truecaller's future results.

• Click here to discover the nuances of Truecaller with our detailed financial health report.

Seize The Opportunity

• Dive into all 52 of the Undervalued Swedish Stocks Based On Cash Flows we have identified here.

• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.

• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include OM:ANOD B OM:RAY B and OM:TRUE B.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]